Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation.
Suzuki T, Tamori A, Matsuura K, Inoue T, Kusumoto S, Hagiwara S, Sagi H, Kaneko A, Murakami S, Kawamra H, Fujiwara K, Aoyagi K, Enomoto M, Kozuka R, Kataoka H, Tanaka Y.
Suzuki T, et al. Among authors: enomoto m.
Ann Hepatol. 2024 Dec 3;30(1):101764. doi: 10.1016/j.aohep.2024.101764. Online ahead of print.
Ann Hepatol. 2024.
PMID: 39638038
Free article.